Skip to main content
. 2016 Jul 15;10:357. doi: 10.3389/fnhum.2016.00357

Table 1.

Characteristics of the sample.

Characteristic Healthy subjects (n = 14) Myofascial pain syndrome (n = 54) Fibromyalgia (n = 19) Osteoarthritis (n = 27) P
Age (years) 32.43 (10.81) 46.13 (12.10) 50.42 (8.84) 64.42 (7.81) 0.00
Body mass index (kg/m2) 23.12 (2.93) 25.22 (4.37) 31.81 (7.08) 28.52 (5.52) 0.00
Years of education 17.14 (2.53) 10.16 (3.61) 13.29 (4.04) 10.37(5.61) 0.00
Employed (yes/no) 14/0 45/9 16/3 19/8 0.19
Smoking (yes/no) 0/14 2/52 5/14 0/27 0.14
History of psychiatric disorder (yes/no)* NA 19/35 7/12 5/22 0.24
Drug active on the nervous system (yes/no)** NA 17/37 11/8 12/15 0.11
Tricyclic antidepressant (yes/no) NA 7/47 7/12 1/26
Selective serotonin reuptake inhibitor (yes/no) NA 8/46 9/10 6/21
Anticonvulsants (yes/no) NA 4/50 1/18 0/27
Benzodiazepine NA 1/53 2/17 5/22
Chronic disease (yes/no) NA 11/8 16/38 20/7 0.00
Hypertension (yes/no) NA 14/40 10/9 14/13
Diabetes mellitus (yes/no) NA 5/49 1/18 4/23
Asthma (yes/no) NA 1/53 3/16 3/24
Number of analgesic doses used per week (≥4 doses-week/<4 doses) NA 27/26 14/5 20/6 0.04
Pain on the VAS (last 7 days) NA 7.23 (2.19) 7.94 (1.89) 6.26 (2.15) 0.03
Pain on the VAS (24 h) NA 6.11 (2.59) 7.10 (1.88) 5.37 (2.47) 0.06
Beck depression inventory II NA 13.92 (8.85) 24.47 (11.67) 10.04 (7.18) 0.00
Brazilian portuguese catastrophizing scale (B-PCS) NA 28.26 (12.51) 34.68 (11.69) 22.89 (11.59) 0.00
Serum BDNF (ng/mL) 19.00 (8.79) 29.28 (20.01) 50.78 (16.06) 17.91 (7.27) 0.00

Data are presented as mean (standard deviation) or number of subjects (n = 114). *Patients could have none or more than one psychiatric disorder. **Some patients were using more than one type of drug. Abbreviations: visual analog scale for pain, from 0 to 10 (VAS); brain-derived neurotrophic factor (BDNF).